Details of the Drug

General Information of Drug (ID: DMN9VKM)

Drug Name

Dasiprotimut-T

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00091676) Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma. U.S. National Institutes of Health.